Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04079166
Title SCIB1 in Melanoma Patients Receiving Either Nivolumab With Ipilimumab or Pembrolizumab (The SCOPE Study)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Scancell Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Velindre University NHS Trust RECRUITING Cardiff United Kingdom Details
Guy's & St Thomas' NHS Foundation Trust NOT_YET_RECRUITING London United Kingdom Details
Royal Free London NHS Foundation Trust RECRUITING London United Kingdom Details
East and North Hertfordshire NHS Trust RECRUITING Northwood United Kingdom Details
Nottingham University Hospitals NHS Trust RECRUITING Nottingham United Kingdom Details
Oxford University Hospital NHS Foundation Trust RECRUITING Oxford United Kingdom Details
University Hospital Plymouth NHS Trust RECRUITING Plymouth United Kingdom Details
Lancashire Teaching Hospitals NHS Foundation Trust RECRUITING Preston United Kingdom Details
Sheffield Teaching Hospital NHS Foundation Trust RECRUITING Sheffield United Kingdom Details
University Hospital Southampton NHS Foundation Trust RECRUITING Southampton United Kingdom Details
Somerset NHS Foundation Trust RECRUITING Taunton United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field